Viewpoint｜Institute for Biotechnology and Medicine Industry│IBMI

Viewpoint

Date	Subject	Author
2026-01-14	An Interview with President Chi-Huey Wong of IBMI for Healthcare & Life Sciences Review 2026: Taiwan	Julija Lukaityte, PharmaBoardroom
2025-12-29	Hon Hai's Prescription for Smart Healthcare	IBMI
2025-12-05	TFDA Commissioner Outlines Strategy to Expand Smart Medical Devices Globally	IBMI
2025-08-12	Exclusive Interview with Ascendo Biotechnology: Innovative CD11b Immunotherapy Enters Phase 1 Clinical Trials, Aiming for New Breakthroughs in Cancer Treatment	Cancer has long been among the top three causes of death worldwide. Beyond surgery, radiation, and chemotherapy, immunotherapy has recently achieved significant advances, signaling a more comprehensive approach to cancer treatment. Current immunotherapies mainly involve immune checkpoint inhibitors targeting molecules such as CTLA-4, PD-1, and PD-L1, which enhance immune cell activity to better recognize and eliminate tumor cells.
2023-05-26	LE TEMPS interview with Prof. Chi-Huey Wong: A universal vaccine against COVID-19 will soon begin clinical trials	LE TEMPS
2021-05-31	Discovery Channel Interview Questions and Answers	Chi-Huey Wong, President of IBMI